NEVVI Medicare utilization intelligence

← back

CHONG, DANIELM.D. NPI 1942462601 Clinician

Hematology-Oncology · FAIRFAX, VA

Specialty Hematology-Oncology — from billed Medicare claims
Trained UNIVERSITY OF VIRGINIA SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 18 years since medical school (class of 2008, self-reported to CMS)
Location FAIRFAX, VA · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 64 codes billed · 43,119 disclosed volume (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
VIRGINIA CANCER SPECIALISTS, P.C.
2019–2026
INOVA HEALTH CARE SERVICES
2024

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-03

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Volume Beneficiary-episodes Avg charge Avg Medicare payment
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J1439 Injection, ferric carboxymaltose, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
J9041 Injection, bortezomib, 0.1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
80053 Blood test, comprehensive group of blood chemicals
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
88185 Flow cytometry technique for dna or cell analysis, each additional marker
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
82784 Gammaglobulin (immune system protein) measurement
36415 Insertion of needle into vein for collection of blood sample
83883 Nephelometry, test method using light
J1626 Injection, granisetron hydrochloride, 100 mcg
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96375 Injection of additional new drug or substance into vein
96413 Administration of chemotherapy into vein, 1 hour or less
84165 Protein measurement, serum
86334 Immunologic analysis technique on serum (immunofixation)
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
82232 Beta-2 microglobulin (protein) level
J3489 Injection, zoledronic acid, 1 mg
96372 Injection of drug or substance under skin or into muscle
83615 Lactate dehydrogenase (enzyme) level
96415 Administration of chemotherapy into vein, each additional hour
84153 Psa (prostate specific antigen) measurement, total
84443 Blood test, thyroid stimulating hormone (tsh)
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
J3490 Unclassified drugs
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96417 Administration of additional new drug or substance into vein, 1 hour or less
83735 Magnesium level
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
82378 Carcinoembryonic antigen (cea) protein level
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
85046 Red blood count automated, with additional calculations
83010 Haptoglobin (serum protein) level
88184 Flow cytometry technique for dna or cell analysis, first marker
96361 Infusion into a vein for hydration, each additional hour
84439 Thyroxine (thyroid chemical), free
96411 Administration of additional new drug or substance into vein using push technique
82607 Cyanocobalamin (vitamin b-12) level
84436 Thyroxine (thyroid chemical), total
84480 Thyroid hormone, t3 measurement, total
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J7030 Infusion, normal saline solution , 1000 cc
82746 Folic acid level, serum
84550 Uric acid level, blood
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
90653 Influenza vaccine, inactivated
G0008 Administration of influenza virus vaccine
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
38222 Biopsy and aspiration of bone marrow sample for diagnosis

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.